Page last updated: 2024-09-04
myricanol and ether
myricanol has been researched along with ether in 1 studies
Compound Research Comparison
| Studies (myricanol) | Trials (myricanol) | Recent Studies (post-2010) (myricanol) | Studies (ether) | Trials (ether) | Recent Studies (post-2010) (ether) |
|---|---|---|---|---|---|
| 14 | 0 | 12 | 4,266 | 39 | 782 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chai, KQ; Chen, X; Dai, GH; Fan, CJ; Li, ZH; Nie, XJ; Ren, ZM; Tong, YL | 1 |
Other Studies
1 other study(ies) available for myricanol and ether
| Article | Year |
|---|---|
The mechanistic antitumor study of myricanol 5-fluorobenzyloxy ether in human leukemic cell HL-60.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 9; Cyclin-Dependent Kinase Inhibitor p21; Diarylheptanoids; Down-Regulation; Ether; Fas Ligand Protein; fas Receptor; G2 Phase Cell Cycle Checkpoints; HL-60 Cells; Humans; Leukemia; M Phase Cell Cycle Checkpoints; Proto-Oncogene Proteins c-bcl-2; Up-Regulation | 2017 |